Rationale
The evidence for treatment of
bipolar depression has been summarised in NICE and SIGN guidelines.
The use of selective serotonin reuptake inhibitors (SSRIs) is less
likely to provoke manic episodes when compared with drugs from the
tri-cyclic class.
Examples of evidence required to meet standard
23:
- Depression screening algorithm
- Antidepressant prescribing protocol
- Outcome measure tools